Diagnostic modalities based on flow cytometry for chronic granulomatous disease: a multicenter study in a well-defined cohort. J Allergy Clin Immunol Pract. 2020.
Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation. J Clin Immunol. 2021.
Therapeutic options for CTLA-4 Insufficiency. J Allergy Clin Immunol. 2021.